Aligos Therapeutics, Inc. (ALGS)
5.76
-0.45
(-7.25%)
USD |
NASDAQ |
Sep 08, 16:00
6.40
+0.64
(+11.11%)
After-Hours: 07:48
Aligos Therapeutics Total Assets (Quarterly) : 66.33M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.33M |
| March 31, 2026 | 64.56M |
| December 31, 2025 | 89.58M |
| September 30, 2025 | 109.76M |
| June 30, 2025 | 134.71M |
| March 31, 2025 | 150.70M |
| December 31, 2024 | 71.85M |
| September 30, 2024 | 88.43M |
| June 30, 2024 | 108.81M |
| March 31, 2024 | 127.90M |
| December 31, 2023 | 153.90M |
| September 30, 2023 | 85.85M |
| Date | Value |
|---|---|
| June 30, 2023 | 106.13M |
| March 31, 2023 | 121.74M |
| December 31, 2022 | 149.86M |
| September 30, 2022 | 164.07M |
| June 30, 2022 | 182.52M |
| March 31, 2022 | 210.47M |
| December 31, 2021 | 239.14M |
| September 30, 2021 | 263.07M |
| June 30, 2021 | 211.88M |
| March 31, 2021 | 234.54M |
| December 31, 2020 | 268.97M |
| September 30, 2020 | 92.18M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 34.44M |
| Shareholders Equity (Quarterly) | 31.88M |
| Debt to Equity Ratio | 0.1099 |
| Current Ratio | 2.192 |
| Net Debt Paydown Yield | 2.43% |